p.128 抽出テキスト

先天性心疾患,心臓大血管の構造的疾患(structural heart disease) に対するカテーテル治療のガイドライン

126. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv 2006; 68: 620-628. PMID: 16969878 127. Carminati M, Butera G, Chessa M, et al. Investigators of the European VSD Registry. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007; 28: 2361-2368. PMID: 17684082 128. Santhanam H, Yang L, Chen Z, et al. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol 2018; 254: 75-83. PMID: 29273241 129. Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol 2014; 63: 1159-1168. PMID: 24509270 130. Wollenek G, Wyse R, Sullivan I, et al. Closure of muscular ventricular septal defects through a left ventriculotomy. Eur J Cardiothorac Surg 1996; 10: 595-598. PMID: 8875164 131. Stellin G, Padalino M, Milanesi O, et al. Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy. Ann Thorac Surg 2000; 69: 597-601. PMID: 10735705 132. 櫻井一,前田正信,佐井昇,他.筋性部肉柱部型心室中隔欠損症例の検討. 胸部外科 1999; 52: 471-476. PMID: 10380475 133. Serraf A, Lacour-Gayet F, Bruniaux J, et al. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J Thorac Cardiovasc Surg 1992; 103: 437-443. PMID: 1545542 134. Holzer R, Balzer D, Cao QL, et al. Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004; 43: 1257-1263. PMID: 15063439 135. Diab KA, Cao QL, Mora BN, et al. Device closure of muscular ventricular septal defects in infants less than one year of age using the Amplatzer devices: feasibility and outcome. Catheter Cardiovasc Interv 2007; 70: 91-98. PMID: 17585388 136. Hijazi ZM. Device closure of ventricular septal defects. Catheter Cardiovasc Interv 2003; 60: 107-114. PMID: 12929113 137. Amin Z, Cao QL, Hijazi ZM. Closure of muscular ventricular septal defects: Transcatheter and hybrid techniques. Catheter Cardiovasc Interv 2008; 72: 102-111. PMID: 18546234 138. Gray RG, Menon SC, Johnson JT, et al. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: A multicenter PICES investigation. Catheter Cardiovasc Interv 2017; 90: 281-289. PMID: 28805027 139. Feltes TF, Bacha E, Beekman RH III, et al. American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2607-2652. PMID: 21536996 140. deleted in proof 141. Porstmann W, Wierny L, Warnke H. The closure of the patent ductus arteriosus without thoractomy. (preliminary report). [Article in German] Thoraxchir Vask Chir 1967; 15: 199-203. PMID: 5239283 142. Rashkind WJ, Cuaso CC. Transcatheter closure of patent ductus arteriosus: Successful use in a 3.5-kilogram infant. Pediatr Cardiol 1979; 1: 3-7. 143. Rashkind WJ, Mullins CE, Hellenbrand WE, et al. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation 1987; 75: 583-592. PMID: 3545534 144. Cambier PA, Kirby WC, Wortham DC, et al. Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol 1992; 69: 815-816. PMID: 1546662 145. Lloyd TR, Fedderly R, Mendelsohn AM, et al. Transcatheter occlusion of patent ductus arteriosus with Gianturco coils. Circulation 1993; 88: 1412-1420. PMID: 8403287 146. Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877-880. PMID: 2929450 147. Hijazi ZM, Geggel RL. Results of anterograde transcatheter closure of patent ductus arteriosus using single or multiple Gianturco coils. Am J Cardiol 1994; 74: 925-929. PMID: 7977123 148. Akagi T, Hashino K, Sugimura T, et al. Coil occlusion of patent ductus arteriosus with detachable coils. Am Heart J 1997; 134: 538-543. PMID: 9327713 149. Grifka MD RG, Jones TK. Transcatheter closure of large PDA using 0.052” gianturco coils: controlled delivery using a bioptome catheter through a 4 French sheath. Catheter Cardiovasc Interv 2000; 49: 301-306. PMID: 10700063 150. Kumar RK, Krishnan MN, Venugopal K, et al. Bioptome-assisted simultaneous delivery of multiple coils for occlusion of the large patent ductus arteriosus. Catheter Cardiovasc Interv 2001; 54: 95-100. PMID: 11553958 151. Hijazi ZM, Geggel RL. Transcatheter closure of large patent ductus arteriosus (> or = 4 mm) with multiple Gianturco coils: immediate and mid-term results. Heart 1996; 76: 536-540. PMID: 9014805 152. Lloyd TR, Beekman RH, Moore JW et al. The PDA coil registry: report of the first 535 procedures. Circulation 1995; 92 suppl: I380. 153. Magee AG, Huggon IC, Seed PT, et al. Association for European Cardiology. Transcatheter coil occlusion of the arterial duct; results of the European Registry. Eur Heart J 2001; 22: 1817-1821. PMID: 11549304 154. Kumar RK. Patent ductus arteriosus: coil occlusion. In: Sievert H, Qureshi SA, Wilson N, editors. Percutaneous interventions for congenital heart disease. Informa Healthcare, 2007: 385-401. 155. Tomita H, Fuse S, Akagi T, et al. Hemolysis complicating coil occlusion of patent ductus arteriosus. Cathet Cardiovasc Diagn 1998; 43: 50-53. PMID: 9473189 156. Anil SR, Sivakumar K, Philip AK, et al. Clinical course and management strategies for hemolysis after transcatheter closure of patent arterial ducts. Catheter Cardiovasc Interv 2003; 59: 538-543. PMID: 12891623 157. Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 2004; 44: 513-519. PMID: 15358013 158. Mullins CE. Transcatheter occlusion of the patent ductus arteriosus (PDA). In: Mullins CE, editor. Cardiac catheterization in congenital heart disease: pediatric and adult. Blackwell Futura, 2006: 693-727. 159. Alwi M. PDA occlusion with the Amplatzer devices. In: Sievert H, Qureshi SA, Wilson N, editors. Percutaneous interventions for congenital heart disease. Informa Healthcare, 2007: 377-384. 160. Saliba Z, El-Rassi I, Abi-Warde MT, et al. The Amplatzer Duct Occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol 2009; 22: 496-502. PMID: 19780890 161. Masri S, El Rassi I, Arabi M, et al. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta. Catheter Cardiovasc Interv 2015; 86: E66-E72. PMID: 26032159 162. Liddy S, Oslizlok P, Walsh KP. Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices. Catheter Cardiovasc Interv 2013; 82: 253-259. PMID: 23427043 163. Sathanandam SK, Gutfinger D, O’Brien L, et al. Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≧700 grams. Catheter Cardiovasc Interv 2020; 96: 1266-1276. PMID: 32433821 164. Delaney JW, Fletcher SE. Patent ductus arteriosus closure using the Amplatzer® vascular plug II for all anatomic variants. Catheter Cardiovasc Interv 2013; 81: 820-824. PMID: 23074167 165. Lloyd TR, Beekman RH III. Clinically silent patent ductus arteriosus. Am Heart J 1994; 127: 1664-1665. PMID: 8198009 166. Bennhagen RG, Benson LN. Silent and audible persistent ductus arteriosus: an angiographic study. Pediatr Cardiol 2003; 24: 27-30. PMID: 12370792 167. Fischer G, Stieh J, Uebing A, et al. Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder. Heart 2001; 86: 444-447. PMID: 11559687 168. Kang SL, Jivanji S, Mehta C, et al. Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: A national study from United Kingdom and Ireland. Catheter Cardiovasc Interv 2017; 90: 1135-1144. PMID: 28799706 169. Kusuda S, Fujimura M, Uchiyama A, et al. Neonatal Research Network, Japan. Trends in morbidity and mortality among very-lowbirth-weight infants from 2003 to 2008 in Japan. Pediatr Res 2012; 72: 531-538. PMID: 22922774 170. Little DC, Pratt TC, Blalock SE, et al. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 2003; 38: 492- 496. PMID: 12632374 171. Coulthard MG. Maturation of glomerular filtration in preterm and mature babies. Early Hum Dev 1985; 11: 281-292. PMID: 4054047 172. Zahn EM, Peck D, Phillips A, et al. Transcatheter Closure of Patent Ductus Arteriosus in Extremely Premature Newborns: Early Results and Midterm Follow-Up. JACC Cardiovasc Interv 2016; 9: